Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimosiamose 5% cream in chronic plaque psoriasis (Phase 2)
2008-000197-20Phase 2Completed
- Sponsor
- Revotar Biopharmaceuticals
- Start
- Oct 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis comparing Bimosiamose 5% cream with Placebo cream (2 arms). Primary endpoint: mPASI 50 at week 16. Started Oct 2008; status: completed.
02
Drugs
bimosiamose
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2008-000197-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000197-20.